SCHEMBL206333

SCHEMBL206333

FC(F)(F)Oc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 8/20 0.77
VCP P55072 5/20 0.67
CFTR P13569 1/20 0.54
PTGS2 P35354 4/20 0.53
MEN1 O00255 3/20 0.52
MAPT P10636 3/20 0.52
KMT2A Q03164 3/20 0.52
NPC1 O15118 2/20 0.52
GAA P10253 2/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
EIF4E P06730 1/20 0.51
ABL1 P00519 2/20 0.49
KDM4E B2RXH2 1/20 0.48
PTGES O14684 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
DEGS1 O15121 1/20 0.48
MAP4K4 O95819 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205618 0.87 ALOX5 (1.00) ALOX5VCPPTGS2MEN1MAPT
SCHEMBL206506 0.83 ALOX5 (0.80) ALOX5VCPPTGS2MEN1MAPT
SCHEMBL205976 0.82 ALOX5 (0.80) ALOX5VCPCFTRPTGS2MEN1
SCHEMBL1818525 0.82 ALOX5 (0.77) ALOX5VCPPTGS2MEN1MAPT
SCHEMBL206148 0.81 ALOX5 (0.66) ALOX5VCPCFTRMEN1MAPT
SCHEMBL5325600 0.80 ALOX5 (1.00) ALOX5VCPCFTRMEN1MAPT
SCHEMBL10246014 0.80 ALOX5 (0.76) ALOX5VCPCFTRMEN1MAPT
SCHEMBL205485 0.78 ALOX5 (0.61) ALOX5VCPCFTRPTGS2MEN1
SCHEMBL4558920 0.77 ALOX5 (0.71) ALOX5VCPCFTRPTGS2MEN1
SCHEMBL208320 0.77 VCP (0.71) ALOX5VCPCFTRMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885CFTR 111/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885CFTR 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.